Singapore Medical Group to delist on Jan 20
CATALIST-LISTED Singapore Medical Group (SMG) will delist on Friday (Jan 20) following its successful privatisation by top SMG executives.
The move comes a month after offeror TLW Success received 95.1 per cent of valid acceptances for its bid to take the specialist healthcare provider private for S$0.40 per share.
TLW Success is jointly owned in equal measure between SMG’s non-executive chairman Tony Tan Choon Keat, chief executive Beng Teck Liang and executive director Wong Seng Weng.
The trio had initially sought to take over SMG at S$0.37 per share via a voluntary conditional offer launched in September 2022.
This was later raised to S$0.40 per share, implying a 16.8 per cent premium over the stock’s net asset value, and 357.1 per cent over the net tangible asset value per share as of Dec 31, 2021.
The offer turned unconditional in November after the total shares TLW Success and its concert parties owned, controlled or agreed to acquire, and the valid acceptances crossed the 90 per cent threshold.
GET BT IN YOUR INBOX DAILY
Start and end each day with the latest news stories and analyses delivered straight to your inbox.
Shares of SMG last traded at S$0.395 on Dec 19, 2022.
KEYWORDS IN THIS ARTICLE
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Companies & Markets
Japan may have spent 5.5 trillion yen on Apr 29 intervention, BOJ data suggests
3M to cut dividend on health-care spin, losing aristocrat status
OCBC should be seen as ‘financial conglomerate’ unlike local banking peers, says chairman
HSBC CEO to retire; bank reports 1.7% lower Q1 profit of US$10.8 billion
McDonald's sales miss estimates as customers cut back spending
Coca-Cola raises annual organic sales forecast on global demand, higher prices